Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice

Masayuki Ishizaki1, Ryuta Muromoto, Toshihiko Akimoto

  • 1Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Insights

Tyrosine kinase-2 (Tyk2) is crucial for arthritis development. Tyk2-deficient mice showed no arthritis symptoms, indicating Tyk2

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Tyrosine kinase-2 (Tyk2) is involved in cytokine signaling in immune responses.
  • Cytokine signaling plays a role in the pathogenesis of autoimmune diseases like arthritis.

Purpose of the Study:

  • To investigate the role of Tyk2 in anti-type II collagen antibody-induced arthritis (CAIA) in vivo.
  • To determine if Tyk2 deficiency protects against arthritis development.

Main Methods:

  • Utilized Tyk2-deficient mice and wild-type littermates.
  • Induced arthritis using anti-type II collagen antibodies (CAIA model).
  • Assessed clinical signs of arthritis, inflammatory cell infiltration, cartilage fibrillation, and cytokine/matrix metalloprotease production.

Main Results:

  • Wild-type mice developed severe arthritis with swelling and erythema.
  • Tyk2-deficient mice exhibited no signs of arthritis, inflammation, or cartilage damage.
  • Tyk2 deficiency significantly reduced pro-inflammatory cytokines (Th1/Th17) and matrix metalloproteases in the affected paws.

Conclusions:

  • Tyk2 plays a critical role in the development of CAIA.
  • Tyk2 deficiency confers protection against arthritis.
  • Tyk2 is a potential therapeutic target for drug development in arthritis treatment.